Kirk Jensen

1.2k total citations
32 papers, 934 citations indexed

About

Kirk Jensen is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Kirk Jensen has authored 32 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Kirk Jensen's work include Thyroid Cancer Diagnosis and Treatment (18 papers), Cancer-related Molecular Pathways (7 papers) and Metabolism, Diabetes, and Cancer (7 papers). Kirk Jensen is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (18 papers), Cancer-related Molecular Pathways (7 papers) and Metabolism, Diabetes, and Cancer (7 papers). Kirk Jensen collaborates with scholars based in United States, Ukraine and Albania. Kirk Jensen's co-authors include Vasyl Vasko, Aneeta Patel, Kenneth D. Burman, Joanna Kłubo-Gwieździńska, Andrew J. Bauer, Vasily Vasko, Leonard Wartofsky, Adel K. El‐Naggar, Peng Hou and Zhi Liu and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer Research and The Journal of Pathology.

In The Last Decade

Kirk Jensen

32 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kirk Jensen United States 17 477 455 356 188 119 32 934
Lindsey N. Jackson United States 15 165 0.3× 473 1.0× 210 0.6× 126 0.7× 72 0.6× 19 856
Junaid Abdulghani United States 11 95 0.2× 424 0.9× 323 0.9× 165 0.9× 91 0.8× 14 739
Ulrika Liljedahl Sweden 14 151 0.3× 329 0.7× 122 0.3× 118 0.6× 143 1.2× 21 765
Yu Ma China 15 90 0.2× 337 0.7× 199 0.6× 245 1.3× 35 0.3× 36 679
Dianne J. Beveridge Australia 16 113 0.2× 582 1.3× 89 0.3× 275 1.5× 90 0.8× 24 848
Yukiko Shibahara Japan 16 67 0.1× 348 0.8× 190 0.5× 227 1.2× 99 0.8× 40 678
Alexander Hermani Germany 8 197 0.4× 622 1.4× 156 0.4× 193 1.0× 135 1.1× 8 847
Yuping Chen China 15 107 0.2× 681 1.5× 263 0.7× 139 0.7× 104 0.9× 41 1.2k
Stephen M. Edwards United Kingdom 15 105 0.2× 538 1.2× 173 0.5× 281 1.5× 147 1.2× 22 933
Maria Grazia Prisco Italy 16 58 0.1× 310 0.7× 316 0.9× 117 0.6× 131 1.1× 22 761

Countries citing papers authored by Kirk Jensen

Since Specialization
Citations

This map shows the geographic impact of Kirk Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Jensen more than expected).

Fields of papers citing papers by Kirk Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Jensen. The network helps show where Kirk Jensen may publish in the future.

Co-authorship network of co-authors of Kirk Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Kirk Jensen. A scholar is included among the top collaborators of Kirk Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk Jensen. Kirk Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kushchayeva, Yevgeniya, Vasyl Vasko, Kirk Jensen, et al.. (2025). Differentiated Thyroid Cancer in Severe Insulin Resistance. PubMed. 12(4). 229–240. 1 indexed citations
2.
Shobab, Leila, Kirk Jensen, Matthew McCoy, et al.. (2024). Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer. Cancers. 16(7). 1260–1260. 2 indexed citations
3.
Gomes-Lima, Cristiane, Leila Shobab, Di Wu, et al.. (2021). Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?. Frontiers in Endocrinology. 12. 623182–623182. 13 indexed citations
4.
5.
Jensen, Kirk, Athanasios Bikas, Aneeta Patel, et al.. (2017). Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer cells. Endocrine Related Cancer. 24(3). 147–156. 27 indexed citations
6.
Kłubo-Gwieździńska, Joanna, Kirk Jensen, Aneeta Patel, et al.. (2017). Amifostine does not protect thyroid cancer cells in DNA damaging in vitro models. Endocrine Connections. 6(7). 469–478. 6 indexed citations
7.
Bikas, Athanasios, et al.. (2016). Targeted therapies in thyroid cancer: an extensive review of the literature. Expert Review of Clinical Pharmacology. 9(10). 1299–1313. 30 indexed citations
8.
Bikas, Athanasios, Kirk Jensen, Aneeta Patel, et al.. (2015). Glucose-deprivation increases thyroid cancer cells sensitivity to metformin. Endocrine Related Cancer. 22(6). 919–932. 49 indexed citations
9.
Kushchayeva, Yevgeniya, Kirk Jensen, Kenneth D. Burman, & Vasyl Vasko. (2014). Repositioning therapy for thyroid cancer: new insights on established medications. Endocrine Related Cancer. 21(3). R183–R194. 12 indexed citations
10.
Kłubo-Gwieździńska, Joanna, John Costello, Aneeta Patel, et al.. (2013). Treatment With Metformin Is Associated With Higher Remission Rate in Diabetic Patients With Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 98(8). 3269–3279. 93 indexed citations
11.
Kłubo-Gwieździńska, Joanna, Kirk Jensen, John Costello, et al.. (2012). Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. Endocrine Related Cancer. 19(3). 447–456. 72 indexed citations
12.
Pinsker, Jordan E., et al.. (2012). Transient Hypothyroidism in Premature Infants After Short-term Topical Iodine Exposure: An Avoidable Risk?. Pediatrics & Neonatology. 54(2). 128–131. 17 indexed citations
13.
Kłubo-Gwieździńska, Joanna, Kirk Jensen, Andrew J. Bauer, et al.. (2012). The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress. Journal of Endocrinology. 214(2). 207–216. 17 indexed citations
14.
Jensen, Kirk, Aneeta Patel, Joanna Kłubo-Gwieździńska, Andrew J. Bauer, & Vasyl Vasko. (2011). Inhibition of gap junction transfer sensitizes thyroid cancer cells to anoikis. Endocrine Related Cancer. 18(5). 613–626. 26 indexed citations
15.
Patel, Aneeta, Joanna Kłubo-Gwieździńska, О. С. Ларін, et al.. (2011). BRAF V600E Mutation Analysis from May-Grünwald Giemsa-Stained Cytological Samples as an Adjunct in Identification of High-Risk Papillary Thyroid Carcinoma. Endocrine Pathology. 22(4). 195–199. 16 indexed citations
16.
Ларін, О. С., et al.. (2010). Thyroid Fine Needle Aspiration Biopsies in Children: Study of Cytological-Histological Correlation and Immunostaining with Thyroid Peroxidase Monoclonal Antibodies. International Journal of Pediatric Endocrinology. 2010. 1–5. 11 indexed citations
17.
Jensen, Kirk, Aneeta Patel, О. С. Ларін, et al.. (2010). Human herpes simplex viruses in benign and malignant thyroid tumours. The Journal of Pathology. 221(2). 193–200. 26 indexed citations
18.
Jensen, Kirk, et al.. (2010). Dynamic changes in E-cadherin gene promoter methylation during metastatic progression in papillary thyroid cancer. Experimental and Therapeutic Medicine. 1(3). 457–462. 22 indexed citations
19.
Roberts, Stephen S., et al.. (2009). GABA Receptor Expression in Benign and Malignant Thyroid Tumors. Pathology & Oncology Research. 15(4). 645–650. 29 indexed citations
20.
Liu, Zhi, Peng Hou, Meiju Ji, et al.. (2008). Highly Prevalent Genetic Alterations in Receptor Tyrosine Kinases and Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase Pathways in Anaplastic and Follicular Thyroid Cancers. The Journal of Clinical Endocrinology & Metabolism. 93(8). 3106–3116. 307 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lindsey N. Jackson Breakdown of academic impact, for papers by Junaid Abdulghani Breakdown of academic impact, for papers by Ulrika Liljedahl Breakdown of academic impact, for papers by Yu Ma Breakdown of academic impact, for papers by Dianne J. Beveridge Breakdown of academic impact, for papers by Yukiko Shibahara Breakdown of academic impact, for papers by Alexander Hermani Breakdown of academic impact, for papers by Yuping Chen Breakdown of academic impact, for papers by Stephen M. Edwards Breakdown of academic impact, for papers by Maria Grazia Prisco
Rankless by CCL
2026